Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure

European Heart Journal

Volumn 20, Issue 9, 1999, Pages 683-693

  Anker, S D ^a,b   Ponikowski, P P ^a   Clark, A L ^a   Leyva, F ^a   Rauchhaus, M ^a   Kemp, M ^c   Teixeira, M M ^a   Hellewell, P G ^a   Hooper, J ^c   Poole Wilson, P A ^a   Coats, A J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Body composition; Cachexia; Cytokines; Heart failure

Indexed keywords

CYTOKINE; HYDROCORTISONE; INTERLEUKIN 6; NEUROHORMONE; PRASTERONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY COMPOSITION; BONE MASS; BONE TISSUE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; HEART FAILURE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LEAN BODY WEIGHT; LEG; MAJOR CLINICAL STUDY; MALE; METABOLISM; MUSCLE TISSUE; PRIORITY JOURNAL; WASTING SYNDROME;

ADULT; AGED; BODY COMPOSITION; CATECHOLAMINES; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYDROCORTISONE; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; WASTING SYNDROME;

EID: 0032961878     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1446     Document Type: Article

References (35)

1. Katz AM, Katz PB. Diseases of the heart in the works of Hippocrates. Br Heart J. 24:1962;257-264.
2. Anker SD, Ponikowski P, Varney S. Wasting as an independent risk factor of survival in chronic heart failure. Lancet. 349:1997;1050-1053.
3. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med. 271:1964;403-409.
4. Poehlmann ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med. 121:1994;860-862.
5. Carr JG, Stevenson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemiac or idiopathic dilated cardiomyopathy. Am J Cardiol. 63:1989;709-713.
6. Buchanan N, Keen RD, Kingsley R, Eyberg CD. Gastrointestinal absorption studies in cardiac cachexia. Intensive Care Med. 3:1997;89-91.
7. Levin B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl Med. 323:1990;236-241.
8. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J. 66:1991;356-358.
9. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumor necrosis factor a in severe congestive cardiac failure. Br Heart J. 70:1993;141-143.
10. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 92:1995;1479-1486.
11. Anker SD, Chua TP, Swan JW. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure: the importance for cardiac cachexia. Circulation. 96:1997;526-534.
12. Thomas RD, Silverton NP, Burkinshaw L, Morgan DB. Potassium depletion and tissue loss in chronic heart disease. Lancet. 310:1979;9-11.
13. Mancini DM, Walter G, Reichek N. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 85:1992;1364-1373.
14. Minotti JR, Christoph I, Weiner MW, Wells L, Massie BM. Impaired skeletal muscle function in patients with congestive heart failure. J Clin Invest. 88:1991;2077-2082.
15. Lee AH, Rebekah LM, Keenan GF. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med. 96:1994;35-41.
16. Volterrani M, Clark AL, Ludman PF. Predictors of exercise capacity in chronic heart failure. Eur Heart J. 15:1994;801-809.
17. Anker SD, Clark AL, Kemp M. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol. 30:1997;997-1001.
18. Fuller NJ, Laskey MA, Elia M. Assessment of the composition of major body regions by dual-energy X-ray absorptiometry (DEXA), with special reference to limb muscle mass. Clin Physiol. 12:1992;253-266.
19. Mazess R, Collick B, Trempe J, Barden H, Hanson J. Performance evaluation of a dual-energy X-ray bone densitometry. Calcif Tissue Int. 44:1989;228-232.
20. Mazess RB, Barden H, Bisek JP, Hanson J. Dual-energy X-ray absorptiometry for total-body and regional bone mineral and soft-tissue composition. Am J Clin Nutr. 51:1990;1106-1112.
21. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body fat distribution. Am J Clin Nutr. 55:1992;950-954.
22. Vescovo G, Serafini F, Facchin L. Specific changes in skeletal muscle myosin heavy chains composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart. 76:1996;337-343.
23. Simioni A, Long CS, Yue P, Dudley GA, Massie BM. Heart failure in rats causes changes in skeletal muscle phenotype and gene expression unrelated to locomotor activity (Abstr). Circulation. 92 (Suppl 1):1995;I-259.
24. Lang CC, Chomsky DB, Rayos G, Yeoh TK, Wilson JR. Skeletal muscle mass and exercise performance in stable ambulatory patients with heart failure. J Appl Physiol. 82:1997;257-261.
25. Toth MJ, Gottlieb SS, Fisher ML, Poehlman ET. Skeletal muscle atrophy and peak oxygen consumption in heart failure. Am J Cardiol. 79:1997;1267-1269.
26. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS, Oliver MF. Insulin resistance in chronic heart failure. Eur Heart J. 15:1994;1528-1532.
27. Underwood LE, Van Wyk JJ. Normal and aberrant growth. Williams Textbook of Endocrinology. 1992;W. B. Saunders, Philadelphia. p. 1079-138.
28. Mann DL, Young JB. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest. 105:1994;897-904.
29. Packer M. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation. 92:1995;1379-1382.
30. Tracey, KJ, Morgello, S, Koplin, B, Metabolic effects of cachectin/tumor necrosis factor are modified by site of production: Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia, J Clin Invest, 86, 2014, 24.
31. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest. 83:1989;1614-1622.
32. Bellido T, Jilka RL, Boyce BF. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. J Clin Invest. 95:1995;2886-2895.
33. Katz SD, Rao R, Berman JW. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation. 90:1994;12-16.
34. Nozaki N, Yamaguchi S, Nakamura H, Takahashi K, Tomoike H. Two types of soluble tumor necrosis factor (TNF) receptors are increased in relation to severity in heart failure (Abstr). Circulation. 90:1994;I-381.
35. National Center for Health Statistics, Weight by height and age for adults 18-74 years: United States 1971-1974. Vital and health statistics. Series 11. Washington D.C. Government Printing Office 1979. 79, 1656.